Pharmacokinetics of melatonin in man after intravenous infusion and bolus injection
- PMID: 2340850
- DOI: 10.1007/BF00315035
Pharmacokinetics of melatonin in man after intravenous infusion and bolus injection
Abstract
The pharmacokinetics of melatonin during the day-time has been studied in 4 healthy subjects after a bolus i.v. injection of 5 or 10 micrograms/person and after a 5 h infusion of 20 micrograms per person in 6 healthy subjects. In addition, a pinealomectomized patient whose nocturnal plasma melatonin had been abolished was investigated after the i.v. infusion--once during the night and once during the day. The clearance of melatonin from blood showed a biexponential decay. The pharmacokinetic parameters in the two studies were similar, except for the disappearance rate constant beta and the apparent volume of distribution at steady-state (Vss). Supplementary peaks or troughs were superimposed on the plateau and the falling part of the profile. They were not due to stimulation of endogenous secretion, because they were also seen in the pinealomectomized patient. During the melatonin infusion, the plasma hormone level reached a steady-state after 60 and 120 min, and when it was equal to the nocturnal level. The infusion regime may be valuable in replacing blunted hormonal secretion in disease states.
Similar articles
-
Nocturnal plasma melatonin profile and melatonin kinetics during infusion in status migrainosus.Cephalalgia. 1997 Jun;17(4):511-7; discussion 487. doi: 10.1046/j.1468-2982.1997.1704511.x. Cephalalgia. 1997. PMID: 9209772
-
Absence of circadian rhythm in the disposition of melatonin in the cow.J Pineal Res. 1993 Oct;15(3):141-6. doi: 10.1111/j.1600-079x.1993.tb00521.x. J Pineal Res. 1993. PMID: 8106960
-
Pharmacokinetics of the infusion of alfentanil in man.Br J Anaesth. 1983 Nov;55(11):1077-81. doi: 10.1093/bja/55.11.1077. Br J Anaesth. 1983. PMID: 6416281
-
Pharmacokinetics of oral and intravenous melatonin in healthy volunteers.BMC Pharmacol Toxicol. 2016 Feb 19;17:8. doi: 10.1186/s40360-016-0052-2. BMC Pharmacol Toxicol. 2016. PMID: 26893170 Free PMC article. Clinical Trial.
-
Pharmacokinetics of high-dose intravenous melatonin in humans.J Clin Pharmacol. 2016 Mar;56(3):324-9. doi: 10.1002/jcph.592. Epub 2015 Sep 14. J Clin Pharmacol. 2016. PMID: 26184078 Clinical Trial.
Cited by
-
PORTAL: pilot study on the safety and tolerance of preoperative melatonin application in patients undergoing major liver resection: a double-blind randomized placebo-controlled trial.BMC Surg. 2008 Jan 23;8:2. doi: 10.1186/1471-2482-8-2. BMC Surg. 2008. PMID: 18215253 Free PMC article. Clinical Trial.
-
Melatonin: From Pharmacokinetics to Clinical Use in Autism Spectrum Disorder.Int J Mol Sci. 2021 Feb 2;22(3):1490. doi: 10.3390/ijms22031490. Int J Mol Sci. 2021. PMID: 33540815 Free PMC article. Review.
-
Melatonin in Cancer Treatment: Current Knowledge and Future Opportunities.Molecules. 2021 Apr 25;26(9):2506. doi: 10.3390/molecules26092506. Molecules. 2021. PMID: 33923028 Free PMC article. Review.
-
Melatonin: possible implications for the postoperative and critically ill patient.Intensive Care Med. 2006 Mar;32(3):371-9. doi: 10.1007/s00134-005-0061-x. Epub 2006 Feb 14. Intensive Care Med. 2006. PMID: 16477412 Review.
-
Melatonin Delivery: Transdermal and Transbuccal Evaluation in Different Vehicles.Pharm Res. 2016 Jul;33(7):1615-27. doi: 10.1007/s11095-016-1901-9. Epub 2016 Mar 8. Pharm Res. 2016. PMID: 26956459
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources